AZBioPEERS Tales from the Road with Kiran Avancha

In this enlightening conversation with Kiran Avancha, co-founder of priZm Therapeutics, a late-stage clinical biotech company based in Chandler, Arizona shares his journey building a company focused on developing breakthrough therapies for ultra-rare pediatric diseases—including their lead program, SRW101, a novel synthetic T3 molecule for treating AHDS (Allan-Herndon-Dudley Syndrome).Continue reading